Spyre Therapeutics (SYRE) Q2 2021 Earnings

5AugExpected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-8.75
-5.89
-3.03
-0.16

Details

Expected EPS
-0.1644
Actual EPS
-2.5
Surprise EPS
-2.34
Surprise Percent
+1,420.68%

Description

Spyre Therapeutics (SYRE) has reported earnings of -2.5 per share for Q2 2021.

0 Comments

Share your thoughts